DEF 14A: National Vision Holdings Seeks Stockholder Approval for Amended Incentive Plan and Director Elections at 2024 Annual Meeting

Sentiment:

Proxy Statement


National Vision Holdings is holding its 2024 Annual Meeting of Stockholders on June 12, 2024, to vote on director elections, executive compensation, and an amendment to the 2017 Omnibus Incentive Plan.

Capital raiseThe Board is requesting that stockholders vote in favor of amending our 2017 Omnibus Incentive Plan (the Equity Plan) to increase the number of shares of the Company's common stock reserved for issuance under the plan by an additional 5.6 million shares.

Summary

  • National Vision Holdings, Inc. is soliciting proxies for its 2024 Annual Meeting of Stockholders to be held on June 12, 2024.
  • The meeting will cover the election of eight director nominees, an advisory vote on executive compensation (Say-on-Pay), an advisory vote on the frequency of future Say-on-Pay votes, approval of an amendment to the 2017 Omnibus Incentive Plan, and ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2024.
  • The Board of Directors recommends voting FOR all director nominees, FOR the Say-on-Pay proposal, ONE YEAR for the frequency of Say-on-Pay votes, FOR the amendment to the incentive plan, and FOR the ratification of Deloitte & Touche LLP.
  • 2023 was a year of business transformation with strong results above expectations, including 70 new store openings, improved optometrist retention, remote care expansion, and store digitization efforts.
  • The company's store partnership with Walmart ended in February 2024, with the transition of 229 Walmart Vision Center stores completed.
  • Key financial results for 2023 include a 4.4% increase in overall store count to 1,413, comparable store sales growth of 3.1%, net revenue increase of 6% to $2,126.5 million, and a net loss of $(65.9) million.
  • Adjusted Operating Income was $72.3 million, and Adjusted Diluted EPS was $0.64.
  • The company returned $25.0 million to stockholders through share repurchases and had cash flows from operating activities of $173.0 million.

Sentiment

Score: 7

Explanation: The document presents a mix of positive and negative results, with a focus on strategic initiatives and future potential. The sentiment is cautiously optimistic, reflecting both challenges and opportunities.

Positives

  • The company opened 70 new stores in 2023.
  • Optometrist retention improved, and recruitment reached a record high.
  • Remote care offering expanded to nearly 550 Americas Best locations.
  • Store digitization efforts are advancing with the rollout of Electronic Health Records.
  • The company's philanthropic efforts helped 1.4 million people around the world to see better.
  • Comparable store sales growth was 3.1% in 2023.
  • Net revenue increased 6% over 2022 to $2,126.5 million.
  • Cash flows from operating activities were $173.0 million in 2023.

Negatives

  • Net income (loss) of $(65.9) million and Diluted EPS of $(0.84), inclusive of non-cash impairment charges of $79.7 million and $7.0 million in expenses related to the termination of the Walmart partnership.
  • Adjusted Operating Income of $72.3 million compared with $87.8 million in fiscal year 2022.
  • Adjusted Diluted EPS of $0.64 compared with $0.65 in fiscal year 2022.

Risks

  • The uncertain macro environment and inflationary pressures may weigh on profitability in the near-term.
  • Investments in key initiatives may impact near-term profitability.

Future Outlook

While the uncertain macro environment, inflationary pressures and our investments in key initiatives will weigh on profitability in the near-term, we expect to be well positioned for continued success and improved market position longer term.

Management Comments

  • 2023 was a year in which we began to transform our business to better compete in today's marketplace and we finished the year quite strong with results above our expectations for the year.
  • We are grateful to our teams dedication and focus on driving our initiatives to date and believe we remain well positioned to deliver our objectives including driving value for our shareholders.

Industry Context

The document does not explicitly compare National Vision's performance to specific competitors or broader industry trends, but it does mention adapting to compete in today's marketplace and building on progress made with key strategic initiatives.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board RefreshmentAdded one new director (Susan OFarrell) and another longer-tenured director (David M. Tehle) transitioned off the Board.February 2024Brings financial and operational experience to the Board.
Majority VotingAmended bylaws to provide for majority voting in uncontested director elections.2023Enhances corporate governance practices.
Declassified BoardCompleted the phase out of the classified structure of the Board, with all directors standing for election annually.June 12, 2024Enhances corporate governance practices.
Enhanced GovernanceAmended bylaws to permit special meetings of the Board to be called on less than 24 hours notice, enhance procedures for Board review of related party transactions, and align with new universal proxy rules and recent amendments to the DGCL.2023Enhances corporate governance practices.
Clawback PolicyAdopted the Incentive Compensation Recovery Policy, compliant with SEC and Nasdaq requirements.October 2023Enhances corporate governance practices.

Stakeholder Impact

  • Shareholders: The company aims to drive value through strategic initiatives and responsible governance.
  • Employees: The company is committed to supporting employees through training, development, and benefits.
  • Customers: The company focuses on making eye care and eyewear more affordable and accessible.
  • Communities: The company engages in philanthropic efforts to improve vision globally.

Next Steps

  • Stockholders are encouraged to review the proxy materials and submit their vote.
  • The company will continue to strategically progress its SEE+G initiatives, partnerships and infrastructure.

Key Dates

DateDescription
April 15, 2024Record date for determining stockholders eligible to vote at the Annual Meeting.
April 25, 2024Proxy statement made available to stockholders.
June 11, 2024Deadline for submitting votes via Internet or telephone (11:59 p.m. Eastern Time).
June 12, 2024Date of the Annual Meeting of Stockholders (1:00 p.m. Eastern Time).
December 26, 2024Deadline for stockholders to submit proposals for inclusion in the 2025 proxy statement.
February 12, 2025Earliest date for stockholders to submit notice of director nominations or other business for the 2025 Annual Meeting.
March 14, 2025Latest date for stockholders to submit notice of director nominations or other business for the 2025 Annual Meeting.

Keywords

Annual Meeting, Proxy Statement, Director Elections, Executive Compensation, Say-on-Pay, Incentive Plan, Deloitte & Touche, Financial Performance, Store Growth, Optometrists, Remote Care, Digitization, Sustainability, Corporate Governance, National Vision Holdings

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.